266 related articles for article (PubMed ID: 28252668)
1. Aggretin Venom Polypeptide as a Novel Anti-angiogenesis Agent by Targeting Integrin alpha2beta1.
Chung CH; Chang CH; Hsu CC; Lin KT; Peng HC; Huang TF
Sci Rep; 2017 Mar; 7():43612. PubMed ID: 28252668
[TBL] [Abstract][Full Text] [Related]
2. Aggretin, a snake venom-derived endothelial integrin alpha 2 beta 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor.
Chung CH; Wu WB; Huang TF
Blood; 2004 Mar; 103(6):2105-13. PubMed ID: 14630793
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
4. Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition.
Dos Santos PK; Altei WF; Danilucci TM; Lino RLB; Pachane BC; Nunes ACC; Selistre-de-Araujo HS
Biochimie; 2020 Jul; 174():144-158. PubMed ID: 32360415
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
[TBL] [Abstract][Full Text] [Related]
6. Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha(2)beta(1) and GPIb in a phosphatidylinositol 3-kinase independent pathway.
Chung CH; Peng HC; Huang TF
Biochem Biophys Res Commun; 2001 Jul; 285(3):689-95. PubMed ID: 11453648
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
8. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
[TBL] [Abstract][Full Text] [Related]
9. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
10. The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production.
Chung CH; Lin KT; Chang CH; Peng HC; Huang TF
Br J Pharmacol; 2009 Mar; 156(5):846-56. PubMed ID: 19239475
[TBL] [Abstract][Full Text] [Related]
11. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors.
Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS
Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781
[TBL] [Abstract][Full Text] [Related]
12. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
13. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins.
Nakao S; Kuwano T; Ishibashi T; Kuwano M; Ono M
J Immunol; 2003 Jun; 170(11):5704-11. PubMed ID: 12759453
[TBL] [Abstract][Full Text] [Related]
16. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly.
Sweeney SM; DiLullo G; Slater SJ; Martinez J; Iozzo RV; Lauer-Fields JL; Fields GB; San Antonio JD
J Biol Chem; 2003 Aug; 278(33):30516-24. PubMed ID: 12788934
[TBL] [Abstract][Full Text] [Related]
18. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
[TBL] [Abstract][Full Text] [Related]
19. Antimigratory effect of TK1-2 is mediated in part by interfering with integrin alpha2beta1.
Kim HK; Oh DS; Lee SB; Ha JM; Joe YA
Mol Cancer Ther; 2008 Jul; 7(7):2133-41. PubMed ID: 18645023
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
